Para acceder a los documentos con el texto completo, por favor, siga el siguiente enlace: http://hdl.handle.net/2445/104547
dc.contributor.author | Bassat Orellana, Quique |
---|---|
dc.contributor.author | Menéndez, Clara |
dc.date | 2016-12-09T09:09:12Z |
dc.date | 2016-12-09T09:09:12Z |
dc.date | 2016-11-16 |
dc.date | 2016-11-30T19:00:21Z |
dc.identifier.citation | 1473-3099 |
dc.identifier.uri | http://hdl.handle.net/2445/104547 |
dc.format | 2 p. |
dc.format | application/pdf |
dc.language.iso | eng |
dc.publisher | Elsevier |
dc.relation | Reproducció del document publicat a: http://dx.doi.org/10.1016/S1473-3099(16)30459-5 |
dc.relation | The Lancet. Infectious Diseases, 2016 |
dc.relation | http://dx.doi.org/10.1016/S1473-3099(16)30459-5 |
dc.rights | cc by (c) Bassat et al., 2016 |
dc.rights | info:eu-repo/semantics/openAccess |
dc.rights | http://creativecommons.org/licenses/by/4.0/ |
dc.subject | Malària |
dc.subject | Administració de medicaments |
dc.subject | Malaria |
dc.subject | Administration of drugs |
dc.title | Dihydroartemisinin-piperaquine: if it works for control, can we use it for elimination? |
dc.type | info:eu-repo/semantics/article |
dc.type | info:eu-repo/semantics/publishedVersion |
dc.description.abstract |